Eighteen casualties attributed to coronavirus and pneumonia have been verified, according to recent reports.
Latest Statistics on COVID-19 Mortality Rates in Kazakhstan
Let's dive into the latest figures reported by Kazakhstan's Ministry of Health as of June 4, 2025, according to Total.kz.
15 unlucky souls have succumbed to COVID-19 in Kazakhstan. Here's a break down:
- Nur-Sultan: 3
- Karaganda region: 4
- Shymkent: 2
- Almaty, Atyrau, Kyzylorda, Mangystau, Pavlodar regions, and West Kazakhstan region: 1 each
On the same day, 89 cases of pneumonia with COVID-19 signs were recorded, with three fatalities in Nur-Sultan, Almaty, and Zhambyl regions.
Since August 1, there have been 55,783 recorded cases of pneumonia, 931 of which were fatal, and 51,501 recovered.
While we have these grim figures, it's worth noting that the death rate of confirmed cases stands at approximately 0.98%, remarkably lower than Liberia's 3.6%. However, Kazakhstan's case load per capita is relatively higher compared to other countries.
Regrettably, detailed subnational or regional mortality data and specific trends since August 1 of any particular year couldn't be found in the current search results. To grasp a comprehensive understanding of Kazakhstan's COVID-19 mortality trends since August 1 of any recent year, it's highly recommended to consult Kazakhstan's Ministry of Health's official COVID-19 dashboards, national epidemiological reports, or WHO regional databases directly. Such sources might not be publicly accessible yet, but they'll undoubtedly provide you with the intricate details you seek.
Now you've got the lowdown... let that sink in! But remember, these statistics are subject to change, so stay informed and protect yourself and your dear ones!
Science reveals that Kazakhstan's COVID-19 mortality rates, though lower than some countries like Liberia, show a higher case load per capita compared to others. Despite this, mental health and overall health-and-wellness remain essential topics in managing the pandemic, as medical-conditions such as pneumonia and its complications continue to pose risks.
